These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23524910)

  • 1. Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure: implications for novel therapeutic strategies.
    Rubattu S; Calvieri C; Pagliaro B; Volpe M
    J Hypertens; 2013 Jun; 31(6):1061-72. PubMed ID: 23524910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Natriuretic peptide system].
    Itoh H; Nakao K
    Nihon Rinsho; 1997 Aug; 55(8):1923-36. PubMed ID: 9284403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atrial natriuretic peptide. II. Pathophysiology and possible clinical significance. Review].
    Vollmar AM
    Tierarztl Prax; 1990 Aug; 18(4):319-22. PubMed ID: 2145657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopeptidase inhibition: a new concept in blood pressure management.
    Burnett JC
    J Hypertens Suppl; 1999 Feb; 17(1):S37-43. PubMed ID: 10340842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptides and their therapeutic potential.
    Cho Y; Somer BG; Amatya A
    Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure.
    Schmitt M; Gunaruwan P; Payne N; Taylor J; Lee L; Broadley AJ; Nightingale AK; Cockcroft JR; Struthers AD; Tyberg JV; Frenneaux MP
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):911-7. PubMed ID: 15001459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface metallopeptidases involved in blood pressure regulation: structure, inhibition and clinical perspectives.
    Roques BP
    Pathol Biol (Paris); 1998 Mar; 46(3):191-200. PubMed ID: 9769915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical implications of current natriuretic peptide research.
    Sagnella GA
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):304-15. PubMed ID: 11967816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Conditions of secretion and peripheral effects of atrial natriuretic peptide in heart failure].
    Riegger AJ
    Z Kardiol; 1988; 77 Suppl 5():77-86. PubMed ID: 2975895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dual endopeptidase inhibitors--a new direction in the development of hypertensive agents].
    Horký K
    Vnitr Lek; 2000 Mar; 46(3):148-51. PubMed ID: 11048516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atrial and B-type natriuretic peptides: from the research lab to clinical practice].
    Boomsma F; van den Meiracker AH
    Ned Tijdschr Geneeskd; 2003 Apr; 147(16):743-8. PubMed ID: 12731463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
    Bauer WR; Neubauer S; Obitz G; Ertl G
    J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atrial natriuretic peptide as angiotensin II antagonist. A new therapeutic principle?].
    Pfaffendorf M
    Med Monatsschr Pharm; 1992 Jun; 15(6):169-77. PubMed ID: 1535414
    [No Abstract]   [Full Text] [Related]  

  • 15. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions.
    Imura H; Nakao K; Itoh H
    Front Neuroendocrinol; 1992 Jul; 13(3):217-49. PubMed ID: 1334000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases.
    Chang MS; Lowe DG; Lewis M; Hellmiss R; Chen E; Goeddel DV
    Nature; 1989 Sep; 341(6237):68-72. PubMed ID: 2570358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
    Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of natriuretic peptides in cardioprotection.
    Nishikimi T; Maeda N; Matsuoka H
    Cardiovasc Res; 2006 Feb; 69(2):318-28. PubMed ID: 16289003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic factor: implications in congestive heart failure and hypertension.
    Burnett JC
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():41-6. PubMed ID: 2528638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a natriuretic peptide family and their clinical application.
    Matsuo H
    Can J Physiol Pharmacol; 2001 Aug; 79(8):736-40. PubMed ID: 11558683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.